Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
Overview | Financials
Company Name | Agios Pharmaceuticals, Inc. |
Symbol | AGIO |
Currency | USD |
Price | 32.86 |
Market Cap | 1,874,012,372 |
Dividend Yield | 0% |
52-week-range | 20.96 - 62.58 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Brian M. Goff M.B.A. |
Website | https://www.agios.com |
An error occurred while fetching data.
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD